NCT00456586View on ClinicalTrials.gov

12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2003

Conditions
Parkinson's Disease
Interventions
DRUG

KW-6002 (istradefylline)

Trial Locations (1)

08540

Contact Kyowa Pharmacuetical Inc., Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.
All Listed Sponsors
lead

Kyowa Kirin, Inc.

INDUSTRY

NCT00456586 - 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa | Biotech Hunter | Biotech Hunter